China Health Resource Passes Major Provincial Inspection

SICHUAN, China, Dec. 8, 2011 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), through its wholly owned subsidiary Suining Yinfa DAR Industrial Co, Ltd (Yinfa), the only the provider of pharmaceutical GAP quality DAR in the People's Republic of China under the registered Trademark Chuan Baizhi™, announces it has passed a major provincial inspection by the Sichuan Province Agricultural Department.

"This is a major step for the company in ensuring the company's commitment to setting the highest quality standard for the TCM pharmaceutical industry," said Jiayin Wang, Chairman and CEO of CHRI.

The inspection was headed by the Director of Sichuan Provincial Agricultural Department, Mr. Yongchang Ren who inspected the status of the "Chuan DAR" industrialization project carried out by Yinfa.

CHRI's CEO Jiayin Wang and senior staff presented a comprehensive report on the major project undertaken by the company's subsidiary Yinfa to Mr. Ren. The report included the following 6 categories:

1. Improved management of City's planting area and increase in the company sales
2. Improvement of local TCM farmers' income
3. Completion of R&D Products
4. Completion of technical and DAR projects
5. Increase in company's intellectual property rights
6. Flourishing of Farmer's DAR Association

Director Ren gave high recognition on the company's recent year's achievements, and encouraged the company to maintain its newly acquired Dragonhead Enterprise status which grants certain government support such as reduced taxation. Director Ren advised CHRI's management to keep good development momentum and to continue leading the mass TCM farmers towards a better life. Mr. Ren said to the company that it should focus more on making high quality and branded products.

About CHRI

China Health Resource, Inc. engages in the development, manufacturing, processing, marketing and sale of raw and pharmaceutical TCM products including Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae and is the only the provider of GAP quality DAR in the People's Republic of China under the registered Trademark Chuan Baizhi™. DAR, which is also known as "Bai Zhi" in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The Company's DAR-related products include the Bailing Capsule, Yisheng Capsule, Kimchee-Mate and Fragrant Bag, all of which are sold through regional distributors. The Company was founded in 2001 and is based in Suining, Sichuan Province.

Certain statements in this document regarding financial matters, other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words "believe", "expect", "anticipate", "optimistic", "intend", "will", and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.

SOURCE China Health Resource, Inc.